Can a smartphone app improve safety for breast cancer patients on oral chemo?
NCT ID NCT05743686
First seen Mar 25, 2026 · Last updated Jun 10, 2026 · Updated 14 times
Summary
This study tested whether a smartphone app could help monitor side effects in 28 women with metastatic breast cancer who were taking oral chemotherapy drugs like palbociclib, everolimus, or capecitabine. The goal was to see if the app could reduce the number of calls to nurses and pharmacists and help patients manage their treatment better. The study was completed and focused on understanding how useful the app might be for tracking toxicities.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
St-Sacrement Hospital
Québec, Quebec, G1S4L8, Canada
Conditions
Explore the condition pages connected to this study.